Chronic Daily Headache Epidemiology Forecast 2025-2034

Chronic daily headache represents a group of headache disorders that occur at least 15 days in a month during a 3-month period. Primary chronic daily headaches are reported to affect around 5% of the population, with chronic tension-type headaches, chronic migraine, and transformed migraine considered the most common long-duration types.

Chronic Daily Headache Epidemiology Forecast Report Coverage

The “Chronic Daily Headache Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of chronic daily headache. It projects the future incidence and prevalence rates of chronic daily headache across various populations. The study covers age and type as major determinants of the chronic daily headache-affected population. The report highlights patterns in the prevalence of chronic daily headache over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of chronic daily headache in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Chronic Daily Headache: Disease Overview

Chronic daily headache (CDH) represents a wide number of different headaches, occurring for at least 15 days per month for more than three months. It includes chronic migraine, new daily persistent headaches, medication overuse headaches, and primary stabbing headaches, among others. Anyone can develop chronic daily headaches. However, the common risk factors are being female, anxiety, depression, overuse of headache medication, obesity, and sleep disturbances.

Chronic Daily Headache: Treatment Overview

Chronic daily headache is usually treated with a combination of medication, lifestyle changes, and behavioral therapies. Tricyclic antidepressants and anti-seizure drugs are often prescribed for chronic headaches. Beta blockers are also taken to prevent episodic migraines. Nonsteroidal anti-inflammatory drugs (NSAIDs) can be used for chronic daily headaches, particularly when the patient is withdrawing from other pain relievers.

Epidemiology

The chronic daily headache epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for chronic daily headache by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for chronic daily headache and their trends. The data is broken down into specific categories, such as the total diagnosed cases across different age groups and patient pools.

• Primary chronic daily headaches are reported to affect up to 5% of the population and are categorized into short-duration (less than 4 hours) and long-duration types. The most prevalent long-duration types include chronic tension-type headaches, chronic migraine, and transformed migraine.
• As per the National Center for Health Statistics, National Health Interview Survey (2021), 4.3% of adults reported significant headache or migraine in the past three months, with higher prevalence in women (6.2%) than men (2.2%). Rates were highest in adults aged between 18 and 44 years (women 7.4%, men 2.5%) and lowest in those aged 65 and older (women 3.1%, men 1.5%).
• According to a review article published in the Journal of Headache and Pain (2022), headache disorders of any type affected 52% of the studied populations, with a prevalence of 44.4% in males and 57.8% in females.
• Studies show that more than 90% of chronic daily headache patients suffer from coexisting psychiatric issues, particularly depression, anxiety, or both.

Country-wise Chronic Daily Headache Epidemiology

The chronic daily headache epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of chronic daily headaches varies significantly between countries due to the differences in genetic predisposition, socioeconomic status, healthcare access, and environmental triggers. Lifestyle factors such as diet, physical activity, sleep patterns, and stress levels also influence the prevalence and severity of chronic daily headaches in different regions. In the United States, approximately 5% of the population is affected by severe headaches on a daily or near-daily basis.

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of chronic daily headache based on several factors.
• Chronic Daily Headache Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population, and the unmet needs of chronic daily headaches are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of Chronic Daily Headache epidemiology in the 8 major markets?
• What will be the total number of patients with Chronic Daily Headache across the 8 major markets during the forecast period?
• What was the country-wise prevalence of Chronic Daily Headache in the 8 major markets in the historical period?
• Which country will have the highest number of Chronic Daily Headache patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of Chronic Daily Headache during the forecast period of 2025-2034?
• What are the currently available treatments for Chronic Daily Headache?
• What are the disease risks, signs, symptoms, and unmet needs of Chronic Daily Headache?

This product will be delivered within 3-5 business days.